Abiopharma

News list

Zibbel Sarah 🟡 adjusted position in 532 shares (1 derivative) of Andersons, Inc. (ANDE) at $64.87 Transaction Date: Sep 01, 2026 | Filing ID: 000128

Full text

News bot Sept. 3, 2026, 5:23 p.m.
🔍 Zibbel Sarah (Executive)

Company: Andersons, Inc. (ANDE)

Report Date: 2026-09-01
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,014
- Total shares sold: 2,546
Detailed Transactions and Holdings:
- Acquired 70 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,128.42 | transaction_form_type: 4 | Footnotes: F1
- Sold 602 shares of Common Stock at $64.87 per share (Direct)
  Date: 2026-09-02 | Code: F | equity_swap_involved: 0 | shares_owned_after: 3,526.42 | transaction_form_type: 4 | Footnotes: F2
- Acquired 1,944 shares of Common Stock (Direct)
  Date: 2026-09-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,470.42 | transaction_form_type: 4
- Sold 1,944 shares of RESTRICTED SHARE UNIT (2026) (Derivative)
  Date: 2026-09-02 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3, F4, F4
Footnotes:
- F1: Shares in lieu of cash dividend.
- F2: Shares withheld to cover tax liability.
- F3: Each restricted share unit represents the right to receive, upon vesting, one share of the Issuer's common stock.
- F4: Restricted share units were granted on September 1, 2023 as part of the Issuer's annual equity grant. Restricted share units have a graded vesting schedule over the three-year period from date of grant.